Minimal impact of Covid-19 2.0 on the Indian pharma industry
Minimal impact of Covid-19 2.0 on the Indian pharma industry; FY2022 growth estimated at 7-9%: ICRA In FY2022, ICRA sample…
Dr. T S Kler Padma Bhushan Awardee
MD, DM, MRCP, FRCP(U.K), FACC, D.Sc
Chairman – Fortis Heart Institute Gurugram
Precautions to avoid Corona Virus: